An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast
-
- A. B. Gottlieb
- Tufts University Boston, MAUSA
-
- B. Strober
- NYU Medical Center New York, NYUSA
-
- J. G. Krueger
- The Rockefeller University New York, NYUSA
-
- P. Rohane
- Celgene Corporation Summit, NJUSA
-
- J. B. Zeldis
- Celgene Corporation Summit, NJUSA
-
- C. C. Hu
- Celgene Corporation Summit, NJUSA
-
- C. Kipnis
- Celgene Corporation Summit, NJUSA
収録刊行物
-
- Current Medical Research and Opinion
-
Current Medical Research and Opinion 24 (5), 1529-1538, 2008-04-16
Informa Healthcare
